SENORESNSE12 May 2025

Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q4 and FY 2024-25 scheduled to be held on May 16, 2025 at 04:00 P.M. (IST).

Senores Pharmaceuticals Limited

Date: May 12, 2025

To, Sr. General Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001

To, Sr. General Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E), Mumbai – 400 051

BSE Scrip Code: 544319

NSE Symbol: SENORES

Dear Sir/Madam,

Sub.: Intimation for Earnings Conference Call for Q4 and FY 2024‐25

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that, post announcement of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2025, the Company will hold the earnings conference call for Q4 and FY 2024-25 on Friday, May 16, 2025, at 04:00 P.M. (IST).

The details of the aforesaid earnings conference call are annexed herewith.

The audio recording and transcript of the aforesaid call will be subsequently published on the website of the Company and will be intimated accordingly.

You are requested to take the same on record.

Thanking you.

For Senores Pharmaceuticals Limited

Vinay Kumar Mishra Company Secretary and Compliance Officer ICSI Membership No.: F11464

Enclosures: As above

Senores Pharmaceuticals Limited  1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park,  Ambali Bopal Road, Ahmedabad‐380054, Gujarat, India

P: +91 79 2999 9857  |  E: info@senorespharma.com  W: www.senorespharma.com  |  CIN No.: L24290GJ2017PLC100263

Q4 and FY2024-25 Earnings Call Senores Pharmaceuticals Limited May 16, 2025 at 4:00 pm (IST)

Ambit Capital cordially Pharmaceuticals Limited

invites you

to

the Q4 and FY2024-25 Earnings Call of Senores

Company Representatives

Mr. Swapnil Shah – Managing Director

Mr. Sanjay Majmudar – Chairperson

Mr. Deval Shah – Chief Financial Officer

The teleconference will be moderated by Prashant Nair, Institutional Equities, Ambit Capital.

Conference Call Details Date: May 16, 2025 | Time: 4:00 pm (IST)

Please join the conference via Diamond Pass to avoid wait time. Please click here to register.

Primary Access Numbers

International Toll Free Numbers

We request you to dial in a few minutes prior to the scheduled time.

+91 22 6280 1148 +91 22 7115 8049

Singapore: 800 101 2045

Hong Kong: 800 964 448

USA: 1 866 746 2133

UK: 0 808 101 1573

← All TranscriptsSENORES Stock Page →